Nantahala Capital Management - Q4 2017 holdings

$2.25 Billion is the total value of Nantahala Capital Management's 91 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 36.4% .

 Value Shares↓ Weighting
IWM SellISHARES TRput$463,478,000
-15.0%
3,040,000
-17.4%
20.60%
-23.0%
SGMS BuySCIENTIFIC GAMES CORPcall$172,060,000
+19.5%
3,354,000
+6.8%
7.65%
+8.3%
EXAS  EXACT SCIENCES CORPput$110,334,000
+11.5%
2,100,0000.0%4.90%
+1.1%
SPY SellSPDR S&P 500 ETF TRcall$106,744,000
-29.2%
400,000
-33.3%
4.74%
-35.8%
SPY SellSPDR S&P 500 ETF TRput$106,744,000
-39.3%
400,000
-42.9%
4.74%
-45.0%
HYG NewISHARES TRput$87,260,0001,000,000
+100.0%
3.88%
AABA BuyALTABA INC$81,843,000
+20.9%
1,171,691
+14.7%
3.64%
+9.6%
RH SellRHcall$76,520,000
-9.3%
887,600
-26.0%
3.40%
-17.8%
XBI NewSPDR SERIES TRUSTput$71,978,000848,100
+100.0%
3.20%
FCAU BuyFIAT CHRYSLER AUTOMOBILES Ncall$57,088,000
+44.9%
3,200,000
+45.5%
2.54%
+31.3%
CDXS BuyCODEXIS INC$55,778,000
+29.0%
6,679,954
+2.8%
2.48%
+16.9%
WRLD BuyWORLD ACCEP CORP DEL$41,950,000
+13.3%
519,699
+16.3%
1.86%
+2.7%
CASH  META FINL GROUP INC$41,503,000
+18.2%
447,9520.0%1.84%
+7.1%
LXFR NewLUXFER HOLDINGS PLC$40,880,0002,587,341
+100.0%
1.82%
QURE BuyUNIQURE NV$36,847,000
+242.7%
1,880,890
+68.0%
1.64%
+210.8%
GDEN  GOLDEN ENTMT INC$35,632,000
+33.9%
1,091,3290.0%1.58%
+21.4%
SODA BuySODASTREAM INTERNATIONAL LTDcall$31,653,000
+58.8%
450,000
+50.0%
1.41%
+43.9%
THC NewTENET HEALTHCARE CORPcall$30,320,0002,000,000
+100.0%
1.35%
AKBA BuyAKEBIA THERAPEUTICS INC$28,757,000
+6.9%
1,933,867
+41.4%
1.28%
-3.1%
WRLD  WORLD ACCEP CORP DELcall$28,252,000
-2.6%
350,0000.0%1.26%
-11.7%
SODA SellSODASTREAM INTERNATIONAL LTD$28,136,000
-15.3%
400,000
-20.0%
1.25%
-23.2%
QADA SellQAD INCcl a$26,789,000
+1.2%
689,531
-10.6%
1.19%
-8.3%
THC NewTENET HEALTHCARE CORP$24,972,0001,647,200
+100.0%
1.11%
DLB SellDOLBY LABORATORIES INC$24,501,000
-45.0%
395,170
-49.0%
1.09%
-50.1%
AFI BuyARMSTRONG FLOORING INC$23,744,000
+21.5%
1,403,321
+13.1%
1.06%
+10.1%
TBBK SellBANCORP INC DEL$22,329,000
+8.0%
2,260,013
-9.6%
0.99%
-2.2%
HRB  BLOCK H & R INCput$20,976,000
-1.0%
800,0000.0%0.93%
-10.3%
ARQL BuyARQULE INC$20,167,000
+77.4%
12,222,130
+19.4%
0.90%
+60.9%
ENT BuyGLOBAL EAGLE ENTMT INC$19,925,000
-22.6%
8,700,979
+15.6%
0.89%
-29.8%
DXPE NewDXP ENTERPRISES INC NEW$18,267,000617,750
+100.0%
0.81%
PETS  PETMED EXPRESS INCput$18,200,000
+37.3%
400,0000.0%0.81%
+24.5%
PRTY NewPARTY CITY HOLDCO INC$18,121,0001,298,996
+100.0%
0.80%
HTZGQ  HERTZ GLOBAL HLDGS INCcall$17,680,000
-1.2%
800,0000.0%0.79%
-10.4%
HCA NewHCA HEALTHCARE INCput$17,568,000200,000
+100.0%
0.78%
SGYPQ NewSYNERGY PHARMACEUTICALS DEL$15,610,0007,000,000
+100.0%
0.69%
ONDK BuyON DECK CAP INC$13,110,000
+40.4%
2,284,020
+14.3%
0.58%
+27.3%
ASCMA BuyASCENT CAP GROUP INC$12,837,000
+42.0%
1,117,232
+61.1%
0.57%
+28.9%
JMBA BuyJAMBA INC$11,968,000
+6.2%
1,484,835
+13.9%
0.53%
-3.6%
ELVT BuyELEVATE CREDIT INC$11,544,000
+216.5%
1,533,044
+156.8%
0.51%
+186.6%
CGNT  COGENTIX MED INC$11,466,000
+23.1%
3,639,8530.0%0.51%
+11.6%
RRR NewRED ROCK RESORTS INCput$10,966,000325,000
+100.0%
0.49%
ORM BuyOWENS RLTY MTG INC$10,065,000
-9.7%
628,697
+2.7%
0.45%
-18.1%
OSPRU  OSPREY ENERGY ACQUISITION COunit 07/21/2022$9,990,000
+0.3%
1,000,0000.0%0.44%
-9.0%
AGLE BuyAEGLEA BIOTHERAPEUTICS INC$9,980,000
+26.3%
1,844,673
+15.1%
0.44%
+14.7%
QURE NewUNIQURE NVcall$9,795,000500,000
+100.0%
0.44%
BPI SellBRIDGEPOINT ED INC$6,778,000
-44.8%
816,609
-36.1%
0.30%
-50.0%
DLB  DOLBY LABORATORIES INCcall$6,200,000
+7.8%
100,0000.0%0.28%
-2.1%
FNTE BuyFINTECH ACQUISITION CORP II$5,996,000
+22.4%
604,498
+20.9%
0.27%
+11.2%
BXG NewBLUEGREEN VACATIONS CORP$5,935,000325,000
+100.0%
0.26%
NATR  NATURES SUNSHINE PRODUCTS IN$5,902,000
+13.8%
510,9890.0%0.26%
+3.1%
CCXI BuyCHEMOCENTRYX INC$5,623,000
+11.8%
945,074
+39.4%
0.25%
+1.2%
SHOS BuySEARS HOMETOWN & OUTLET STOR$5,579,000
+38.9%
2,145,651
+36.2%
0.25%
+25.9%
GME  GAMESTOP CORP NEWput$5,385,000
-13.1%
300,0000.0%0.24%
-21.4%
CURO NewCURO GROUP HLDGS CORP$5,280,000375,000
+100.0%
0.24%
BPI  BRIDGEPOINT ED INCcall$4,565,000
-13.5%
550,0000.0%0.20%
-21.6%
TLYS BuyTILLYS INCcl a$4,501,000
+67.4%
304,949
+36.0%
0.20%
+51.5%
XELA NewEXELA TECHNOLOGIES INC$4,382,000850,793
+100.0%
0.20%
LINC BuyLINCOLN EDL SVCS CORP$4,363,000
-14.0%
2,159,705
+6.4%
0.19%
-22.1%
EMMS  EMMIS COMMUNICATIONS CORP$3,847,000
+6.0%
1,092,9510.0%0.17%
-3.9%
CRMT  AMERICAS CAR MART INC$3,766,000
+8.6%
84,3480.0%0.17%
-1.8%
GLMD NewGALMED PHARMACEUTICALS LTD$3,660,000400,000
+100.0%
0.16%
MFCB BuyMFC BANCORP LTD$3,643,000
+145.7%
467,594
+196.1%
0.16%
+121.9%
SHLDQ  SEARS HLDGS CORPcall$3,580,000
-51.0%
1,000,0000.0%0.16%
-55.6%
SHLDQ NewSEARS HLDGS CORPput$3,580,0001,000,000
+100.0%
0.16%
DVD  DOVER MOTORSPORTS INC$3,365,000
-4.9%
1,725,7890.0%0.15%
-13.3%
TWMC SellTRANS WORLD ENTMT CORP$3,309,000
-9.1%
1,813,149
-0.4%
0.15%
-17.9%
TAXA BuyLIBERTY TAX INCcl a$3,005,000
-10.5%
273,198
+17.2%
0.13%
-18.8%
STRM  STREAMLINE HEALTH SOLUTIONS$2,975,000
+15.0%
1,760,2970.0%0.13%
+3.9%
RLGT SellRADIANT LOGISTICS INC$2,416,000
-26.2%
525,300
-14.8%
0.11%
-33.1%
DDE BuyDOVER DOWNS GAMING & ENTMT I$1,924,000
+18.3%
1,886,458
+19.4%
0.09%
+7.5%
UTI  UNIVERSAL TECHNICAL INST INC$1,603,000
-30.8%
667,9460.0%0.07%
-37.7%
PTIE  PAIN THERAPEUTICS INC$1,388,000
-1.8%
347,0530.0%0.06%
-10.1%
CRHM NewCRH MEDICAL CORP$1,258,000477,688
+100.0%
0.06%
LEE  LEE ENTERPRISES INC$1,105,000
+6.9%
470,0000.0%0.05%
-3.9%
FNTEW  FINTECH ACQUISITION CORP II*w exp 01/19/202$345,000
+8.8%
249,9990.0%0.02%
-6.2%
RBCAA  REPUBLIC BANCORP KYcl a$280,000
-2.4%
7,3710.0%0.01%
-14.3%
EPM ExitEVOLUTION PETROLEUM CORP$0-130,615
-100.0%
-0.05%
DNOW ExitNOW INC$0-150,000
-100.0%
-0.10%
AVXS ExitAVEXIS INCput$0-100,000
-100.0%
-0.47%
MDCO ExitMEDICINES COcall$0-300,000
-100.0%
-0.54%
SGMS ExitSCIENTIFIC GAMES CORPcl a$0-500,000
-100.0%
-1.12%
FCFS ExitFIRSTCASH INC$0-430,250
-100.0%
-1.33%
LXFR ExitLUXFER HLDGS PLCsponsored adr$0-2,357,651
-100.0%
-1.44%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-02-14
Signatures

The EDGAR filing(s) were signed by:

About Nantahala Capital Management

Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.

Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.

Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.

Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR42Q3 202327.2%
CODEXIS INC42Q3 20233.9%
PATHWARD FINANCIAL INC35Q3 20236.3%
SCIENTIFIC GAMES CORP34Q3 20225.3%
DOVER MOTORSPORTS INC34Q3 20210.5%
GOLDEN ENTMT INC33Q3 20232.1%
QAD INC32Q3 20212.6%
SCIENTIFIC GAMES CORP31Q4 20217.7%
DOLBY LABORATORIES INC31Q4 20205.6%
LINCOLN EDL SVCS CORP31Q4 20210.7%

View Nantahala Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Nantahala Capital Management Q4 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AYTU BIOPHARMA, INCJune 16, 20231,086,81219.7%
Acer Therapeutics Inc.February 14, 20231,226,1917.5%
Aeglea BioTherapeutics, Inc.February 14, 20234,611,3027.5%
AKUMIN INC.February 14, 20232,206,9602.5%
ALTA EQUIPMENT GROUP INC.February 14, 20231,188,9853.7%
Apollo Endosurgery, Inc.February 14, 20234,056,6279.9%
Autolus Therapeutics plcFebruary 14, 20237,782,0184.7%
Bioventus Inc.February 14, 20233,168,5745.1%
CATALYST BIOSCIENCES, INC.February 14, 2023438,0551.4%
Drive Shack Inc.February 14, 20236,500,0007.0%

View Nantahala Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-21
42024-03-15
SC 13G2024-03-11
13F-HR/A2024-02-15
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Nantahala Capital Management's complete filings history.

Compare quarters

Export Nantahala Capital Management's holdings